A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCA
Clinical trial NCT03742973 · TERMINATED
Trial details
- NCT number
- NCT03742973
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-28
- Primary completion
- 2019-09-26
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.